Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fresenius Kabi
Pharma
J&J inks Stelara patent deal with Fresenius Kabi, Formycon
By inking a third Stelara patent settlement, J&J is getting more clarity around the forthcoming loss of exclusivity for its top product by sales.
Eric Sagonowsky
Aug 7, 2023 10:30am
Fresenius' new CEO signals 'reset' as activist investor circles
Oct 31, 2022 10:29am
Europe's generic drug makers are asking the bloc for a lifeline
Sep 28, 2022 10:49am
Manufacturing will be separator for Humira biosims, AbbVie says
Sep 20, 2022 8:50am
The top 10 generic drug makers by 2021 revenue
Jul 18, 2022 3:00am
In flurry of activity, EMA issues nods for Sanofi, Lilly drugs
May 20, 2022 10:46am
